Thousands of Hindus, Muslims throng Hazrat Khwaja Banda-Nawaz Dargah as 614th Urs begins

Udupi, Jan 25: Mangalore International Airport (MIA) culprit Aditya Rao has revealed that after placing the explosive device he went to Malpe and made threat call of placing bomb in the Indigo flight.

Rao, who is in police custody, on Saturday, was brought to Malpe under tight security by the investigating officer ACP Belliyappa for spot investigation. On January 20, Aditya had come to the Mangaluru airport and planted an explosive device before going to Malpe and made a threat call about placing a bomb in the Indigo flight. He was just a couple of kilometers away from the Malpe police station while making the call.

Sitting outside an egg selling shop which opens only after 6:00 pm, Aditya had called the Airport and informed that a bomb was placed in the Indigo flight. Later he destroyed the sim card and left to Bengaluru to surrender.

Bengaluru, Jan 30: A kidnap case in Bengaluru has proved that crime-based series on TV channels can inspire youth to commit crimes. 21-year-old Chirag R Mehta, who kidnapped a schoolboy and got arrested within an hour after demanding Rs 5 lakh ransom, has told police that he thought of abducting the boy after watching Crime Patrol, a popular Hindi crime anthology series created by Subramanian S. lyer for Sony TV. The kidnapped schoolboy was rescued by the police and reunited with his parents. Son of a gift shop owner from Basavanagudi area in Bengaluru, Chirag has reportedly told police that decided to make some quick money to spend on cricket betting and gambling after learning kidnap tricks from the ‘Crime Patrol’. According to police, Chirag reached a private school around 3pm on Tuesday on a Bounce rental bike and zeroed in on a fourth standard student who was walking out of school. He told the boy he was his father's friend and that he required help to search for a relative who had gone missing. The boy believed Chirag and rode pillion on the bike. Chirag then engaged the boy in conversation and learnt about his father's business and got his mobile phone number. He then made a call to the boy's father, demanded Rs 5 lakh and warned him against approaching cops. However, the boy's father alerted Cottonpet police and special teams were formed to crack the case. While Cottonpet inspector Venkatesh TC's squad verified CCTV footage in and around the school, Chamarajpet inspector BG Kumaraswamy's team started tracking the suspect's mobile phone movements. An hour later, the suspect's location was traced to a hotel on the Lavelle Road-St Mark's Road stretch. Police rushed there, rescued the boy and arrested Chirag.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.